A photo of M. Christa Krupski.

M. Christa Krupski, DO, MPH


  • Member, Division of Bone Marrow Transplantation and Immune Deficiency
  • Assistant Professor, UC Department of Pediatrics
I am detail-oriented and love problem-solving. Most of all, I find it rewarding to offer patients with leukemia a chance at a curative approach via bone marrow transplant.

About

Biography

I developed an interest in medicine at a very young age, when I was exposed to several physicians who were very passionate about their work. I was invited to shadow these individuals, and as I observed the incredible work they were doing, my own excitement for the field of medicine grew.

Now, as a hematologist/oncologist specializing in bone marrow transplantation, I enjoy educating patients and families and supporting them as they undergo the transplant. My primary interest is in transplantation for malignancies, such as leukemia.

Cincinnati Children’s has one of the largest bone marrow transplant programs in the country. Our team consists of phenomenal physicians — many of whom are experts in various areas of transplant medicine — and countless support staff who ensure optimal care of our patients and their families.

I am detail-oriented and love problem-solving. Most of all, I find it rewarding to offer patients with leukemia a chance at a curative approach via bone marrow transplant. It is incredibly gratifying to work with children because they are so resilient — they laugh and play, even when they are sick. I am continuously amazed by how tough young children are.

My research interests include complications and adverse effects of bone marrow transplant. One project I am working on is optimizing how we manage mucositis (mouth / throat inflammation and sores) pain post-transplant.

Outside the hospital, my husband and I love international travel and spending time outdoors.

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Selected

Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). Lee, PY; Kellner, ES; Huang, Y; Furutani, E; Huang, Z; Bainter, W; Alosaimi, MF; Stafstrom, K; Platt, CD; Stauber, T; et al. Journal of Allergy and Clinical Immunology. 2020; 145:1664-1672.e10.

Selected

Chimeric antigen receptor T-cell therapy in patients with neurologic comorbidities. Rubinstein, JD; Nelson, AS; Krupski, C; O'Brien, W; Taylor, JM; Badgett, TC; Huang, M; Davies, SM; Phillips, CL. Pediatric Blood and Cancer. 2020; 67.

Selected

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors. Holtan, SG; Khera, N; Levine, JE; Chai, X; Storer, B; Liu, HD; Inamoto, Y; Chen, GL; Mayer, S; Arora, M; et al. Blood. 2016; 128:2350-2358.

Application of Infrared Spectroscopy Techniques for Identification of Ancient Vegetation and Soil Change on Loess Areas. Dudek, M; Kabala, C; Labaz, B; Krupski, M. Land. 2022; 11.

Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults. Wang, YZ M; Teusink-Cross, A; Elborai, Y; Krupski, MC; Nelson, AS; Grimley, MS; Flannery, A; Mehta, PA; Bleesing, JJ; Chandra, S; et al. Transplantation. 2022; 106:412-419.

Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia. Breese, EH; Krupski, C; Nelson, AS; Perentesis, JP; Phillips, CL. Journal of Pediatric Hematology/Oncology. 2021; 43:152-154.

Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation. Chandra, S; Chandrakasan, S; Dávila Saldaña, BJ; Bleesing, JJ; Jordan, MB; Kumar, AR; Grimley, MS; Krupski, C; Davies, SM; Khandelwal, P; et al. Journal of Clinical Immunology. 2021; 41:89-98.

CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study. Khandelwal, P; Fukuda, T; Teusink-Cross, A; Kashuba, AD M; Lane, A; Mehta, PA; Marsh, RA; Jordan, MB; Grimley, MS; Myers, KC; et al. Bone Marrow Transplantation. 2020; 55:1552-1559.

231 Amphiregulin Modifies the Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN Acute Gvhd Therapy Trials. Holtan, SG; Defor, TE; Howard, A; Pidala, JA; Levine, JE; Wu, JM; Khera, N; Lee, SJ; Bolaños-Meade, J; Ho, VT; et al. Biology of Blood and Marrow Transplantation. 2018; 24:s177-s178.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey